Ignite Creation Date:
2024-05-06 @ 3:45 PM
Last Modification Date:
2024-10-26 @ 1:56 PM
Study NCT ID:
NCT04748562
Status:
COMPLETED
Last Update Posted:
2021-02-10
First Post:
2021-01-31
Brief Title:
Vaginal Progesterone 400mg vs 200mg for Prevention of Preterm Labor in Twin Pregnancies
Sponsor:
Ain Shams University
Organization:
Ain Shams University
Study Overview
Official Title:
Vaginal Progesterone 400mg vs 200mg for Prevention of Preterm Labor in Twin Pregnancies a Randomised Controlled Trial
Status:
COMPLETED
Status Verified Date:
2021-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
It is already known that the risk of preterm labor in twin pregnancy before 37 week is 8-9 fold higher compared to singletons and progesterone supplementation can decrease the incidence of preterm labor in singleton pregnancy
There were studies that used 200mg vaginal progesterone with no effect on the result So this study aims To examine the effect of prophylactic vaginal progesterone 400mg vs 200mg for prevention of preterm birth in twin pregnancies
There were studies that used 200mg vaginal progesterone with no effect on the result So this study aims To examine the effect of prophylactic vaginal progesterone 400mg vs 200mg for prevention of preterm birth in twin pregnancies
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None